期刊
BIOMARKERS IN MEDICINE
卷 10, 期 1, 页码 35-49出版社
FUTURE MEDICINE LTD
DOI: 10.2217/bmm.15.107
关键词
alpha-synuclein; cerebrospinal fluid biomarkers; cognitive impairment; disease progression; early diagnosis; motor symptoms; parkinsonisms; Parkinson's disease; prognosis
Since diagnosis of Parkinson's disease (PD) is mostly based on clinical criteria, it is almost impossible to formulate an early diagnosis, as well as a timely differential diagnosis versus other parkinsonisms. A great effort in searching reliable biomarkers both for early diagnosis and prognosis in PD is currently ongoing. Cerebrospinal fluid has been widely investigated as potential source for such biomarkers, with particular emphasis on -synuclein (-syn) species. We reviewed all the clinical studies carried out so far on cerebrospinal fluid quantification of -syn species in PD. Current evidence supports the value of total and oligomeric -syn in PD diagnosis and in the differential diagnosis of PD and other parkinsonisms. Conversely, the role of -syn species in PD prognosis remains unsatisfactory.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据